Lower limb angiogenesis with arterio-venous fistulas, a new entity aggravating the long-term clinical course of deep vein thrombosis

Antoine Elias; Agnès Bourrinet; Marie Elias; Hervè Rousseau

doi:10.1055/s-0037-1613646

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2004; 92(01): 214-217
DOI: 10.1055/s-0037-1613646

Letters to the Editor

Schattauer GmbH

Lower limb angiogenesis with arterio-venous fistulas, a new entity aggravating the long-term clinical course of deep vein thrombosis

Autoren

Antoine Elias

¹Rangueil University Hospital Centre, Department of Vascular Medicine, Toulouse, France,
Agnès Bourrinet

¹Rangueil University Hospital Centre, Department of Vascular Medicine, Toulouse, France,
Marie Elias

¹Rangueil University Hospital Centre, Department of Vascular Medicine, Toulouse, France,
Hervè Rousseau

²Rangueil University Hospital Centre, Department of Radiology,Toulouse, France

Abstract

Volltext

Referenzen

References
1 Kroger K, Rudofsky G. Duplex sonography of vascularization of venous thrombosis. Int Angiol 1998; 17: 103-7.
2 Tamura M. Neovascularization in experimental retinal venous obstruction in rabbits. Jpn J Ophthalmol 2001; 45: 144-50.
3 Hashimoto T, Mesa-Tejada R, Quick CM. et al. Evidence of increased endothelial cell turnover in brain arteriovenous malformations. Neurosurgery 2001; 49: 124-31 discussion 131-2..
4 Abdulrauf SI, Malik GM, Awad IA. Spontaneous angiographic obliteration of cerebral arteriovenous malformations. Neurosurgery 1999; 44: 280-7 discussion 287-8..
5 Lawton MT, Jacobowitz R, Spetzler RF. Redefined role of angiogenesis in the pathogenesis of dural arteriovenous malformations. J Neurosurg 1997; 87: 267-74.
6 Pournaras CJ. Retinal oxygen distribution. Its role in the physiopathology of vasoproliferative microangiopathies. Retina 1995; 15: 332-47.
7 Kader A, Goodrich IT, Sonstein WI. et al. Recurrent cerebral arteriovenous malformations after negative postoperative angiograms. I Neurosurg 1996; 85: 14-8.
8 Fernandez PM, Rickles FR. Tissue factor and angiogenesis in cancer. Curr Opin Hematol 2002; 09: 401-6.
9 Ofosu FA. The blood platelet as a model for regulating blood coagulation on cell surfaces and its consequences. Biochemistry (Mosc) 2002; 67: 47-55.
10 Zhou I, Tang Z, Fan I. [Expression rates of three angiogenic factors in hepatocellular carcinoma and their relation with microvessel density and portal vein tumor thrombosis]. Zhonghua Yi Xue Za Zhi 2001; 81: 462-4.
11 Waltham M, Burnand KG, Collins M. et al. Vascular endothelial growth factor and basic fibroblast growth factor are found in resolving venous thrombi. I Vasc Surg 2000; 32: 988-96.
12 Wakefield TW, Linn MJ, Henke PK. et al. Neovascularization during venous thrombosis organization: a preliminary study. I Vasc Surg 1999; 30: 885-92.
13 Henke PK, Wakefield TW, Kadell AM. et al. Interleukin-8 administration enhances venous thrombosis resolution in a rat model. I Surg Res 2001; 99: 84-91.
14 Rodriguez-Nieto S, Chavarria T, Martinez-Poveda B. et al. Anti-angiogenic effects of homocysteine on cultured endothelial cells. Biochem Biophys Res Commun 2002; 293: 497-500.
15 Escudier B, Lassau N, Leborgne S. et al. Thalidomide and venous thrombosis. Ann Intern Med 2002; 136: 711.
16 Agorogiannis EI, Agorogiannis GI. Coagulation, angiogenesis, and venous thromboembolism in cancer. Lancet 2002; 359: 1440.
17 Miller JW, Stinson WG, Folkman I. Regression of experimental iris neovascularization with systemic alpha-interferon. Ophthalmology 1993; 100: 9-14.